Constant Gillot

发表

Serum SARS-CoV-2 Antigens for the Determination of COVID-19 Severity

J. Dogné, J. Douxfils, J. Favresse, 2021, medRxiv.

Head-to-Head Comparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infection

J. Dogné, J. Douxfils, J. Favresse, 2021, Journal of clinical medicine.

Spike vs. nucleocapsid serum antigens for COVID-19 diagnosis and severity assessment

J. Dogné, J. Douxfils, J. Favresse, 2022, Clinical chemistry and laboratory medicine.

Analytical Sensitivity of Six SARS-CoV-2 Rapid Antigen Tests for Omicron versus Delta Variant

J. Dogné, F. Mullier, J. Douxfils, 2022, Viruses.

NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study

C. Beauloye, S. Horman, P. Laterre, 2022, Biomolecules.

Post-SARS-CoV-2 vaccination specific antibody decrease — Thresholds for determining seroprevalence and seroneutralization differ

F. Mullier, J. Douxfils, J. Favresse, 2021, Journal of Infection.

Vaccine‐induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster

J. Dogné, J. Douxfils, J. Favresse, 2022, Journal of medical virology.

Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients

J. Dogné, J. Douxfils, J. Favresse, 2020, Clinical chemistry and laboratory medicine.

Reply to Schulte-Pelkum, J. Comment on “Favresse et al. Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection. Microorganisms 2021, 9, 556”

J. Douxfils, J. Favresse, Constant Gillot, 2021, Microorganisms.

An Original ELISA-Based Multiplex Method for the Simultaneous Detection of 5 SARS-CoV-2 IgG Antibodies Directed against Different Antigens

J. Dogné, J. Douxfils, J. Favresse, 2020, Journal of clinical medicine.

Efficient Maternal to Neonate Transfer of Neutralizing Antibodies after SARS-CoV-2 Vaccination with BNT162b2: A Case-Report and Discussion of the Literature

J. Dogné, J. Douxfils, J. Favresse, 2021, Vaccines.

NETosis and the Immune System in COVID-19: Mechanisms and Potential Treatments

J. Dogné, F. Mullier, J. Douxfils, 2021, Frontiers in Pharmacology.

Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers

J. Dogné, V. Gérin, F. Mullier, 2021, Vaccines.

Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2

J. Dogné, J. Douxfils, J. Favresse, 2021, Viruses.

Persistence of Anti-SARS-CoV-2 Antibodies Depends on the Analytical Kit: A Report for Up to 10 Months after Infection

J. Dogné, J. Douxfils, J. Favresse, 2021, Microorganisms.

Lung Transplant Recipients Immunogenicity after Heterologous ChAdOx1 nCoV-19—BNT162b2 mRNA Vaccination

F. Mullier, J. Douxfils, P. Evrard, 2022, Viruses.

Peri-infection titers of neutralizing and binding antibodies as a predictor of COVID-19 breakthrough infections in vaccinated healthcare professionals: importance of the timing

J. Dogné, J. Douxfils, J. Favresse, 2023, Clinical chemistry and laboratory medicine.

Dynamics of Neutralizing Antibody Responses Following Natural SARS-CoV-2 Infection and Correlation with Commercial Serologic Tests. A Reappraisal and Indirect Comparison with Vaccinated Subjects

J. Dogné, J. Douxfils, J. Favresse, 2021, Viruses.

Resistance towards ChadOx1 nCoV-19 in an 83 Years Old Woman Experiencing Vaccine Induced Thrombosis with Thrombocytopenia Syndrome

J. Dogné, F. Mullier, J. Douxfils, 2022, Vaccines.

Kinetics and ability of binding antibody and surrogate virus neutralization tests to predict neutralizing antibodies against the SARS-CoV-2 Omicron variant following BNT162b2 booster administration

J. Dogné, J. Douxfils, J. Favresse, 2023, Clinical chemistry and laboratory medicine.